Panitumumab and pegylated liposomal doxorubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type: The PaLiDo study, a phase II nonrandomized multicenter study.

Karina Dahl Steffensen; Marianne Waldstrom; Niels Pallisgård; Bente Lund; Kjell Bergfeldt; Jessica Wihl; Nina Keldsen; Christian Marth; Ignace B. Vergote; Anders Kristian Moeller Jakobsen

Panitumumab and pegylated liposomal doxorubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type: The PaLiDo study, a phase II nonrandomized multicenter study.

Karina Dahl Steffensen, Marianne Waldstrom, Niels Pallisgård, Bente Lund, Kjell Bergfeldt, Jessica Wihl, Nina Keldsen, Christian Marth, Ignace B. Vergote, Anders Kristian Moeller Jakobsen

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Journal of Clinical Oncology
Vol/bind	30
Udgave nummer	15
ISSN	0732-183X
Status	Udgivet - 20 maj 2012
Udgivet eksternt	Ja
Begivenhed	American Society of Clinical Oncology - Chicago, USA Varighed: 1 jun. 2012 → 5 jun. 2012 Konferencens nummer: 48

Konference

Konference	American Society of Clinical Oncology
Nummer	48
Land/Område	USA
By	Chicago
Periode	01/06/2012 → 05/06/2012

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Steffensen, K. D., Waldstrom, M., Pallisgård, N., Lund, B., Bergfeldt, K., Wihl, J., Keldsen, N., Marth, C., Vergote, I. B., & Jakobsen, A. K. M. (2012). Panitumumab and pegylated liposomal doxorubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type: The PaLiDo study, a phase II nonrandomized multicenter study. Journal of Clinical Oncology, 30(15).

@article{c4bd528fcc324044af7b1fc345c57309,

title = "Panitumumab and pegylated liposomal doxorubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type: The PaLiDo study, a phase II nonrandomized multicenter study.",

keywords = "Oncology",

author = "Steffensen, {Karina Dahl} and Marianne Waldstrom and Niels Pallisg{\aa}rd and Bente Lund and Kjell Bergfeldt and Jessica Wihl and Nina Keldsen and Christian Marth and Vergote, {Ignace B.} and Jakobsen, {Anders Kristian Moeller}",

note = "PT: J; CT: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); CY: JUN 01-06, 2012; CL: Chicago, IL; SP: Amer Soc Clin Oncol (ASCO); NR: 0; TC: 0; J9: J CLIN ONCOL; SU: S; PG: 1; GA: 131QQ; UT: WOS:000318009803644; American Society of Clinical Oncology ; Conference date: 01-06-2012 Through 05-06-2012",

year = "2012",

month = may,

day = "20",

language = "English",

volume = "30",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15",

}

Panitumumab and pegylated liposomal doxorubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type: The PaLiDo study, a phase II nonrandomized multicenter study. / Steffensen, Karina Dahl; Waldstrom, Marianne; Pallisgård, Niels et al.
I: Journal of Clinical Oncology, Bind 30, Nr. 15, 20.05.2012.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Panitumumab and pegylated liposomal doxorubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type: The PaLiDo study, a phase II nonrandomized multicenter study.

AU - Steffensen, Karina Dahl

AU - Waldstrom, Marianne

AU - Pallisgård, Niels

AU - Lund, Bente

AU - Bergfeldt, Kjell

AU - Wihl, Jessica

AU - Keldsen, Nina

AU - Marth, Christian

AU - Vergote, Ignace B.

AU - Jakobsen, Anders Kristian Moeller

N1 - Conference code: 48

PY - 2012/5/20

Y1 - 2012/5/20

KW - Oncology

M3 - Conference abstract in journal

SN - 0732-183X

VL - 30

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15

T2 - American Society of Clinical Oncology

Y2 - 1 June 2012 through 5 June 2012

ER -